Complete Wegovy vs Mounjaro Comparison Guide
Key Differences When You Switch From Mounjaro to Wegovy
The fundamental difference between these medications lies in their mechanisms of action. When you switch from Mounjaro to Wegovy, you're moving from tirzepatide (a dual GIP and GLP-1 receptor agonist) to semaglutide (a single GLP-1 receptor agonist). This change affects how each medication may support your weight management goals alongside a reduced-calorie diet and increased physical activity. Mounjaro targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors, whilst Wegovy focuses specifically on GLP-1 pathways.
The dosing schedules also differ significantly between these prescription-only medicines. Wegovy follows a 5-step escalation protocol from 0.25mg to 2.4mg maintenance dose over 16 weeks, whilst Mounjaro uses 6 dosing levels from 2.5mg up to 15mg. Your prescriber will determine the appropriate starting dose when you switch from Mounjaro to Wegovy, potentially beginning with Wegovy's standard 0.25mg initiation dose regardless of your previous Mounjaro dose. This careful approach ensures optimal tolerability during the transition period.
Wegovy vs Mounjaro Pricing and Value Comparison
When evaluating costs to switch from Mounjaro to Wegovy, our transparent pricing structure at EverydayMeds makes comparison straightforward. Wegovy 0.25mg starter dose costs £79.99, with prices increasing through the escalation schedule to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) provide convenient two-pen packages for £169.99. New customers benefit from our FIRST40 discount code applied at checkout, whilst returning customers use DOSE25.
Bundle options offer practical advantages for those planning to switch from Mounjaro to Wegovy long-term. Our Intro Trio combines three escalation doses (0.25mg, 0.5mg & 1mg) for £299.99, ensuring 12 weeks of continuous supply with fewer orders. The Ultimate Stability Trio provides three months of 2.4mg maintenance therapy for £649.99. These bundles prioritise convenience and Reliable Supply rather than cost savings, with temperature-controlled delivery maintaining medication integrity throughout.
Clinical Evidence Supporting the Switch From Mounjaro to Wegovy
Wegovy's efficacy profile comes from the comprehensive STEP clinical trial programme. In STEP 1, participants achieved approximately 15% average weight reduction at 68 weeks when taking Wegovy alongside lifestyle interventions, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events (HR 0.80) amongst participants with established cardiovascular disease.
When considering whether to switch from Mounjaro to Wegovy, it's important to note that direct head-to-head comparisons between these medications are limited due to different trial designs and populations. Both treatments have demonstrated efficacy in clinical trials when used alongside reduced-calorie diets and increased physical activity. Your prescriber can evaluate your individual response history and clinical profile to determine if switching treatments aligns with your weight management objectives.
How Wegovy Works After Switching From Mounjaro
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones in your digestive system. Once weekly injection activates GLP-1 receptors in the brain's appetite control centres, potentially reducing food cravings and promoting feelings of fullness after smaller meals. Unlike Mounjaro's dual-target approach, Wegovy focuses specifically on GLP-1 pathways to support weight management. The medication may slow gastric emptying, helping you feel satisfied longer after eating whilst supporting your reduced-calorie diet efforts. This mechanism works continuously between doses, providing consistent appetite regulation throughout the week.
Ordering Process to Switch From Mounjaro to Wegovy
Switching from Mounjaro to Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment. You'll provide details about your current treatment history, including your Mounjaro dosing experience and any side effects encountered. Our GPhC-registered prescribers (#9012878) review your assessment within 3 working days (or 24 hours with express service) to determine if Wegovy represents an appropriate alternative. Once approved, your medication ships via next-day cold-chain delivery to maintain optimal temperature throughout transit. This process ensures clinical safety whilst minimising treatment interruption during your transition period.
Storage and Practical Considerations for Wegovy vs Mounjaro
One notable advantage when you switch from Mounjaro to Wegovy involves storage flexibility for travel and lifestyle convenience. Wegovy pens maintain stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require standard refrigerator storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers greater flexibility for business travel, holidays, or irregular schedules. The FlexTouch pen delivery system provides consistent dosing with clear dose indicators, whilst the weekly injection schedule reduces administration frequency compared to daily medications.
Switching Timeline and Transition Management
The transition period when you switch from Mounjaro to Wegovy requires careful clinical oversight to ensure treatment continuity. Most prescribers recommend completing your current Mounjaro pen before initiating Wegovy, though specific timing depends on your individual circumstances and current dose level. Starting Wegovy typically involves beginning with the standard 0.25mg initiation dose regardless of your previous Mounjaro strength, allowing your system to adjust to the different medication mechanism. This conservative approach minimises potential side effects whilst establishing effective therapeutic levels.
Your prescriber may recommend specific monitoring during the first few weeks after you switch from Mounjaro to Wegovy. Some patients experience temporary changes in appetite regulation or digestive comfort as their system adapts to semaglutide's single-target mechanism compared to tirzepatide's dual-pathway approach. Both Wegovy and Mounjaro are available from EverydayMeds, ensuring consistent supply and clinical support throughout your transition. Our clinical team remains available to address questions or concerns that arise during the switching process, maintaining continuity of care throughout your weight management journey.
Making Your Decision: Wegovy or Mounjaro Access
Both Wegovy and Mounjaro are available from EverydayMeds with identical clinical assessment and prescriber review processes, allowing you to access either medication through one trusted platform. Our GPhC-registered pharmacy (#9012878) maintains comprehensive stock levels for both treatments, eliminating supply concerns that might influence your clinical decision. Whether you choose to switch from Mounjaro to Wegovy or explore other options, our prescriber network can guide you towards the most appropriate prescription-only medicine for your circumstances. Apply discount code FIRST40 for new customers or DOSE25 for returning patients at checkout, and experience the convenience of next-day cold-chain delivery to your door. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discuss your weight management options with qualified healthcare professionals today.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
